Jianxing He
Nanjing University of Chinese Medicine(CN)Beijing University of Posts and Telecommunications(CN)Anhui University(CN)Sun Yat-sen University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Chengdu Medical College(CN)Ningxia University(CN)Sichuan University(CN)China University of Geosciences(CN)Maastricht University(NL)Nanjing University of Science and Technology(CN)Wuhan University(CN)Zhengzhou University(CN)China International Science and Technology Cooperation(CN)National Clinical Research Center for Digestive Diseases(CN)Second Affiliated Hospital of Guangzhou Medical University(CN)Health First(US)First Affiliated Hospital of Guangzhou Medical University(CN)Shanghai University of Traditional Chinese Medicine(CN)Waitemata District Health Board(NZ)Guangdong Provincial Hospital of Traditional Chinese Medicine(CN)Shanghai Institute of Organic Chemistry(CN)Zhongshan Hospital(CN)First Affiliated Hospital of Chengdu Medical College(CN)Ningxia Medical University(CN)Guangzhou Institute of Dermatology(CN)The First Affiliated Hospital, Sun Yat-sen University(CN)Ningxia Medical University General Hospital(CN)First Affiliated Hospital of University of South China(CN)State Key Laboratory of Respiratory Disease(CN)Children's Hospital of Chongqing Medical University(CN)University of Chinese Academy of Sciences(CN)Dazhou Central Hospital(CN)Wuhan University of Science and Technology(CN)Southern Medical University(CN)Zhejiang University(CN)Chongqing Medical University(CN)University of South China(CN)Guangzhou Medical University(CN)
Publications by Year
Research Areas
Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Tracheal and airway disorders, Cancer Genomics and Diagnostics
Most-Cited Works
- → Clinical Characteristics of Coronavirus Disease 2019 in China(2020)31,045 cited
- → Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China(2020)4,570 cited
- → Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial(2019)3,269 cited
- → The practical implementation of artificial intelligence technologies in medicine(2018)2,115 cited
- → Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19(2020)1,507 cited
- → Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions(2020)1,494 cited